120 related articles for article (PubMed ID: 9685244)
41. MMP-13 selective α-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteres.
Barta TE; Becker DP; Bedell LJ; Easton AM; Hockerman SL; Kiefer J; Munie GE; Mathis KJ; Li MH; Rico JG; Villamil CI; Williams JM
Bioorg Med Chem Lett; 2011 May; 21(10):2820-2. PubMed ID: 21507637
[TBL] [Abstract][Full Text] [Related]
42. Metal coordination-based inhibitors of adenylyl cyclase: novel potent P-site antagonists.
Levy DE; Bao M; Cherbavaz DB; Tomlinson JE; Sedlock DM; Homcy CJ; Scarborough RM
J Med Chem; 2003 May; 46(11):2177-86. PubMed ID: 12747789
[TBL] [Abstract][Full Text] [Related]
43. Design and synthesis of acidic dipeptide hydroxamate inhibitors of procollagen C-proteinase.
Ovens A; Joule JA; Kadler KE
J Pept Sci; 2000 Sep; 6(9):489-95. PubMed ID: 11016886
[TBL] [Abstract][Full Text] [Related]
44. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor.
Grams F; Crimmin M; Hinnes L; Huxley P; Pieper M; Tschesche H; Bode W
Biochemistry; 1995 Oct; 34(43):14012-20. PubMed ID: 7577999
[TBL] [Abstract][Full Text] [Related]
45. Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor.
Li YC; Zhang X; Melton R; Ganu V; Gonnella NC
Biochemistry; 1998 Oct; 37(40):14048-56. PubMed ID: 9760240
[TBL] [Abstract][Full Text] [Related]
46. The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.
Park HI; Jin Y; Hurst DR; Monroe CA; Lee S; Schwartz MA; Sang QX
J Biol Chem; 2003 Dec; 278(51):51646-53. PubMed ID: 14532275
[TBL] [Abstract][Full Text] [Related]
47. [Inhibition of synovial collagenase by actinonin. Study of structure/activity relationship].
Lelièvre Y; Bouboutou R; Boiziau J; Cartwright T
Pathol Biol (Paris); 1989 Jan; 37(1):43-6. PubMed ID: 2538794
[TBL] [Abstract][Full Text] [Related]
48. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor.
Van Doren SR; Kurochkin AV; Hu W; Ye QZ; Johnson LL; Hupe DJ; Zuiderweg ER
Protein Sci; 1995 Dec; 4(12):2487-98. PubMed ID: 8580839
[TBL] [Abstract][Full Text] [Related]
49. Preparation of peptidyl hydroxamic acid derivatives which inhibit interstitial collagenases.
Nagai Y; Hattori S; Odake S; Okayama T; Obata M; Morikawa T
Matrix Suppl; 1992; 1():313. PubMed ID: 1480046
[No Abstract] [Full Text] [Related]
50. Interaction of folic acid and some matrix metalloproteinase (MMP) inhibitor folate-γ-hydroxamate derivatives with Zn(II) and human serum albumin.
Enyedy EA; Farkas E; Dömötör O; Santos MA
J Inorg Biochem; 2011 Mar; 105(3):444-53. PubMed ID: 21421131
[TBL] [Abstract][Full Text] [Related]
51. Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.
Novakova Z; Wozniak K; Jancarik A; Rais R; Wu Y; Pavlicek J; Ferraris D; Havlinova B; Ptacek J; Vavra J; Hin N; Rojas C; Majer P; Slusher BS; Tsukamoto T; Barinka C
J Med Chem; 2016 May; 59(10):4539-50. PubMed ID: 27074627
[TBL] [Abstract][Full Text] [Related]
52. Discovery of novel hydroxamates as highly potent tumor necrosis factor-alpha converting enzyme inhibitors: Part I--discovery of two binding modes.
Zhu Z; Mazzola R; Sinning L; McKittrick B; Niu X; Lundell D; Sun J; Orth P; Guo Z; Madison V; Ingram R; Beyer BM
J Med Chem; 2008 Feb; 51(4):725-36. PubMed ID: 18247549
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and activity of selective MMP inhibitors with an aryl backbone.
Barta TE; Becker DP; Bedell LJ; De Crescenzo GA; McDonald JJ; Munie GE; Rao S; Shieh HS; Stegeman R; Stevens AM; Villamil CI
Bioorg Med Chem Lett; 2000 Dec; 10(24):2815-7. PubMed ID: 11133099
[TBL] [Abstract][Full Text] [Related]
54. Structure of human neutrophil collagenase reveals large S1' specificity pocket.
Stams T; Spurlino JC; Smith DL; Wahl RC; Ho TF; Qoronfleh MW; Banks TM; Rubin B
Nat Struct Biol; 1994 Feb; 1(2):119-23. PubMed ID: 7656015
[TBL] [Abstract][Full Text] [Related]
55. X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily.
Dhanaraj V; Ye QZ; Johnson LL; Hupe DJ; Ortwine DF; Dunbar JB; Rubin JR; Pavlovsky A; Humblet C; Blundell TL
Structure; 1996 Apr; 4(4):375-86. PubMed ID: 8740360
[TBL] [Abstract][Full Text] [Related]
56. D-proline-based peptidomimetic inhibitors of anthrax lethal factor.
Calugi C; Trabocchi A; Lalli C; Guarna A
Eur J Med Chem; 2012 Oct; 56():96-107. PubMed ID: 22960696
[TBL] [Abstract][Full Text] [Related]
57. Non-peptidic cysteine derivatives as inhibitors of matrix metalloproteinases.
Müller JC; von Roedern EG; Grams F; Nagase H; Moroder L
Biol Chem; 1997 Dec; 378(12):1475-80. PubMed ID: 9461346
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial N-(2-chlorobenzyl)-substituted hydroxamate is an inhibitor of 1-deoxy-D-xylulose 5-phosphate synthase.
Hayashi D; Kato N; Kuzuyama T; Sato Y; Ohkanda J
Chem Commun (Camb); 2013 Jun; 49(49):5535-7. PubMed ID: 23476925
[TBL] [Abstract][Full Text] [Related]
59. Hydroxamate derivatives of substrate-analogous peptides containing aminomalonic acid are potent inhibitors of matrix metalloproteinases.
Krumme D; Wenzel H; Tschesche H
FEBS Lett; 1998 Oct; 436(2):209-12. PubMed ID: 9781680
[TBL] [Abstract][Full Text] [Related]
60. Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.
Bailey S; Bolognese B; Faller A; Louis-Flamberg P; MacPherson DT; Mayer RJ; Marshall LA; Milner PH; Mistry J; Smith DG; Ward JG
Bioorg Med Chem Lett; 1999 Nov; 9(21):3165-70. PubMed ID: 10560745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
